World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
31358
World Ranking
10506
National Ranking
5407

Charles V. Pollack publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Charles V. Pollack sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 511 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Charles V. Pollack D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Charles V. Pollack sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Charles V. Pollack is affiliated with Thomas Jefferson University in the United States. Their primary research domain is medicine, with a focus on cardiology and cardiovascular medicine, pulmonary and respiratory medicine, internal medicine, surgery, and biomedical engineering.

Their work covers a range of key medical topics, including:

  • Potassium and Related Disorders
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Venous Thromboembolism Diagnosis and Management
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Heart Failure Treatment and Management

Their recent published papers illustrate contributions across several specialized areas. Notable papers include:

  • "Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection," 2020, American Journal of Respiratory and Critical Care Medicine
  • "Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent Surgery," 2021, NEJM Evidence
  • "A review of guidelines on anticoagulation reversal across different clinical scenarios - Is there a general consensus?", 2020, The American Journal of Emergency Medicine
  • "EP-7041, a Factor XIa Inhibitor as a Potential Antithrombotic Strategy in Extracorporeal Membrane Oxygenation: A Brief Report," 2020, Critical Care Explorations
  • "Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia," 2023, BMC Nephrology

Frequent co-authors collaborating with Charles V. Pollack include:

  • Eva Lesén
  • Anjay Rastogi
  • Eiichiro Kanda
  • Toyoaki Murohara
  • Abiy Agiro

Their research appears regularly in several key publication venues, indicating consistent engagement with peer-reviewed journals, including:

  • The American Journal of Cardiology
  • Journal of the American Society of Nephrology
  • Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
  • Circulation
  • UNC Libraries

Best Publications

  • Idarucizumab for Dabigatran Reversal

    Charles V. Pollack;Paul A. Reilly;John Eikelboom;Stephan Glund

  • Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score

    Sumeet Subherwal;Richard G. Bach;Anita Y. Chen;Brian F. Gage

  • Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

    Charles V. Pollack;Paul A. Reilly;Joanne van Ryn;John W. Eikelboom

  • Association between hospital process performance and outcomes among patients with acute coronary syndromes.

    Eric D. Peterson;Matthew T. Roe;Jyotsna Mulgund;Elizabeth R. DeLong

  • Intravenous Platelet Blockade with Cangrelor during PCI

    Deepak L. Bhatt;A. Michael Lincoff;C. Michael Gibson;Gregg W. Stone

  • Platelet Inhibition with Cangrelor in Patients Undergoing PCI

    Robert A. Harrington;Gregg W. Stone;Steven McNulty;Harvey D. White

  • Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes

    Karen P. Alexander;Anita Y. Chen;Matthew T. Roe;L. Kristin Newby

  • Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative

    Deepak L. Bhatt;Matthew T. Roe;Eric D. Peterson;Yun Li

  • Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006

    William J. Rogers;Paul D. Frederick;Edna Stoehr;John G. Canto

  • Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction.

    David J. Magid;Yongfei Wang;Jeph Herrin;Robert L. McNamara

  • Clinical Characteristics, Management, and Outcomes of Patients Diagnosed With Acute Pulmonary Embolism in the Emergency Department: Initial Report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry)

    Charles V. Pollack;Donald Schreiber;Samuel Z. Goldhaber;David Slattery

  • Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE National Quality Improvement Initiative

    Karen P. Alexander;Matthew T. Roe;Anita Y. Chen;Barbara L. Lytle

  • 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

    Gordon F. Tomaselli;Kenneth W. Mahaffey;Adam Cuker;Paul P. Dobesh

  • Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006

    C. Michael Gibson;Yuri B. Pride;Paul D. Frederick;Charles V. Pollack

  • Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial.

    Gilles Montalescot;Uwe Zeymer;Johanne Silvain;Bertrand Boulanger

  • Heavy Metal Toxicity, Part I: Arsenic and Mercury

    Kimberlie A Graeme;Charles V Pollack

  • Early use of inhaled corticosteroids in the emergency department treatment of acute asthma

    Marcia L Edmonds;Stephen J Milan;Carlos A Camargo;Charles V Pollack

  • Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction.

    Elizabeth H. Bradley;Jeph Herrin;Yongfei Wang;Robert L. McNamara

  • Association of intravenous morphine use and outcomes in acute coronary syndromes: Results from the CRUSADE Quality Improvement Initiative

    Trip J. Meine;Matthew T. Roe;Anita Y. Chen;Manesh R. Patel

  • Utilization and Impact of Pre-Hospital Electrocardiograms for Patients With Acute ST-Segment Elevation Myocardial Infarction: Data From the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry

    Deborah B. Diercks;Michael C. Kontos;Anita Y. Chen;Charles V. Pollack

Frequent Co-Authors

Matthew T. Roe
Matthew T. Roe Duke University
W. Brian Gibler
W. Brian Gibler University of Cincinnati
E. Magnus Ohman
E. Magnus Ohman Duke University
Eric D. Peterson
Eric D. Peterson The University of Texas Southwestern Medical Center
Judd E. Hollander
Judd E. Hollander Thomas Jefferson University
Robert A. Harrington
Robert A. Harrington Cornell University
Sidney C. Smith
Sidney C. Smith University of North Carolina at Chapel Hill
Christopher J. Lindsell
Christopher J. Lindsell Vanderbilt University Medical Center
L. Kristin Newby
L. Kristin Newby Duke University
Jeffrey I. Weitz
Jeffrey I. Weitz McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine opens doors to a wide range of related fields and flexible study options. Prospective healthcare professionals may consider leadership roles by enrolling in a healthcare administration degree online, which offers accelerated paths to management positions in hospitals and clinics.

Registered nurses looking to advance their careers can benefit from a rn to np bridge program. These programs provide a streamlined route for nurses to become nurse practitioners—expanding both their scope of practice and earning potential.

For those interested in preventative health and wellness, the best online nutrition programs equip students with evidence-based knowledge to promote healthier lifestyles and work in clinical, corporate, or community settings.

Lastly, future healthcare leaders often seek the best online mha programs. These accredited Master's in Healthcare Administration programs provide advanced skills for organizational leadership in today’s fast-changing medical landscape.

Best Scientists Citing Charles V. Pollack

Trending Scientists

Recently Published Articles